Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 25,590 shares at $91.50 ($2.3M) on 2024-11-06, disclosed to the SEC on 2024-11-07.
Scheduled sale ($2.3M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.50 | 5,000 | $458K | 19.5% |
| 2 | $91.50 | 20,590 | $1.9M | 80.5% |
| Total | $91.50 avg | 25,590 | $2.3M | 100% |
| Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |
| GILD | SELL | 2024-04-02 | $146K | — | Filing → |